Thanks. PNK does look like another short candidate, but IMO ASCA remains an even better one. PNK is priced at its book value while ASCA is 3.5 times its book value. Also, ASCA is just as stressed by debt as PNK although ASCA's new $500 million unsecured note may stave off an actual bankruptcy for the next two years. If things don't improve by then, then ASCA ought to be toast. Also, IMO ASCA's recent dividend and EBITDA "surprise" is more a function of accounting tricks than genuine and real earnings. Nonetheless, IMO ASCA is extraordinarily overvalued at its current price given today's stressed economy and am happy at present with my short position.